-+ 0.00%
-+ 0.00%
-+ 0.00%

China Resources Pharmaceutical Subsidiary CR Double-Crane's Nine-Month Net Profit Falls to RMB 1.31 Billion

PUBT·10/27/2026 09:38:01
Listen to the news
China Resources Pharmaceutical Subsidiary CR Double-Crane's Nine-Month Net Profit Falls to RMB 1.31 Billion
  • CR Double-Crane, a 60.26%-owned subsidiary of China Resources Pharmaceutical Group, released unaudited results for the nine months ended September 30, 2026.
  • Net profit fell to RMB 1.31 billion from a restated RMB 1.4 billion a year earlier.
  • Revenue declined to RMB 8.07 billion from a restated RMB 8.4 billion.
  • Cash and cash equivalents increased by RMB 211.38 million, reversing a year-earlier decrease of RMB 630.39 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261027-12384346), on October 27, 2026, and is solely responsible for the information contained therein.